GOG Foundation
J

New Frontiers of PARPi Therapy in Pancreatic and Biliary Cancers: Tumor Profiling, Chemo for DDR-Defective Tumors, Mechanisms of PARPi Resistance

By GOG Foundation FEATURING James Abbruzzese
By GOG Foundation FEATURING James Abbruzzese
414 views
January 22, 2020
0 Comments
Login to view comments. Click here to Login

Featured Video

20:00
Exelixis

Child-Pugh Classification and its Role in Treatment Decisions in Pat…

Feat. P. Gholam

Featured Video

10:25
Exelixis

Explore the mechanism of Action of a TKI in HCC

Feat. W. Keiser

Related Content

AUTOPLAY
27:37
ASCO GI 2023 Conference Coverage

ASCO GI 2023 Expert Panel Discussion: Practice-Changing Updates

Feat. N. Uboha, A. Turk, K. Spencer, M. Cecchini
23:58
ASCO GI 2023 Conference Coverage

ASCO GI 2023 Key Studies

Feat. R. Kim, R. Mehta
20:07
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Summary: "GI Expert Panel Discussion on Key Trials I…

Feat. Y. Janjigian, S. Cytryn, S. Maron
06:47
UCSF School of Medicine

Tumor-Agnostic Efficacy & Safety of Selpercatinib in RET Fusion+…

Feat. H. Kang
06:03
Total Health

2024 Updates on Targeted Approaches for GI Cancers and New Data in N…

Feat. A. Grothey
03:50
UCLA Health

Perspectives on the Recent FDA Approval of NALIRIFOX in Frontline Me…

Feat. Z. Wainberg
12:08
Yale Cancer Center

GI Oncology Year in Review: Precision Medicine Update in Metastatic …

Feat. J. Lacy
07:53
Total Health

Updates on Pancreatic Cancer - 2023 ASCO® Direct Philadelphia

Feat. D. Lin
34:01
MedNews Week

Latest Treatment Strategies and Standard of Care for Pancreatic Canc…

Feat. M. Pishvaian
06:28
Shubham Pant

FDA Approval of Liposomal Irinotecan/NALIRIFOX in 1L Metastatic Panc…

22:10
Yale Cancer Center

Pancreatic Cancer Updates From Yale Cancer Center

Feat. J. Lacy
10:53
Yale Cancer Center

GI Oncology Year in Review: Metastatic Pancreatic Cancer - NAPOLI-3 …

Feat. J. Lacy
18:35
Rachna Shroff

Augmenting Standard Treatment Options in Pancreatic Cancer

18:35
Total Health

Biliary Cancer Updates - 2023 ASCO® Direct Philadelphia

Feat. D. Lin
06:16
ecancer

ASCO® 2023 Insights: "NAPOLI 3 Analysis of 1L NALIRIFOX vs. Gem…

Feat. E. O’Reilly
28:39
MUSC Health

Precision Medicine in Pancreatic Cancer and the Emerging Role of Gls

Feat. F. Bishehsari
10:41
ASCO GI 2023 Conference Coverage

ASCO GI 2023 NAPOLI-3 Randomized, Open-Label Phase 3 Study: Liposoma…

Feat. Z. Wainberg
08:03
Insights from 2023 ESMO World Congress on Gastrointestinal Cancer Annual Meeting

2023 ESMO WCGIC Insights: "Additional Results From the Phase 3 …

Feat. Z. Wainberg
23:32
The University of Kansas Cancer Center

Updates on Pancreatic Cancer Treatment

Feat. A. Kasi
21:43
OncoAlert

OncoAlert Updates on Pancreatic Cancer

Feat. M. Lewis